TRIDENT LIFELINE
Back to Income Statement
|
TRIDENT LIFELINE Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Consolidated Net Profit | ₹12 Cr | ₹6.34 Cr | ₹6.02 Cr | ₹3.95 Cr |
What is the latest Consolidated Net Profit of TRIDENT LIFELINE ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹12 Cr |
| Mar2024 | ₹6.34 Cr |
| Mar2023 | ₹6.02 Cr |
| Mar2022 | ₹3.95 Cr |
How is Consolidated Net Profit of TRIDENT LIFELINE Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹12 Cr | 85.18 | |
| Mar2024 | ₹6.34 Cr | 5.47 | |
| Mar2023 | ₹6.02 Cr | 52.36 | |
| Mar2022 | ₹3.95 Cr | - | |
Compare Consolidated Net Profit of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹300.5 Cr | 1.7% | 3% | -7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 1.7% |
3% |
-7.1% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses